Company Deep Dive
Business segments breakdown, earnings transcript analysis, management credibility scoring, competitive landscape, and scenario modelling.
ENSG
HoldPremium GrowerThe Ensign Group, Inc. · Healthcare · United States · $10.1B · Avg Vol: $56M/d
COMPANY DESCRIPTION
The Ensign Group, Inc. is a diversified healthcare provider operating skilled nursing, assisted living, home health, and hospice facilities across multiple U.S. states. The company's distinctive decentralized operating model, which empowers local leadership, fosters high-quality patient outcomes and efficient asset management, forming a strong competitive advantage. Ensign is a leading operator in the post-acute care continuum, known for its strategic acquisitions and operational excellence.
FINANCIAL SUMMARY (USD)
| Year | 2021 | 2022 | 2023 | 2024 | 2025 | CAGR | TTM | 2026E | 2027E | Fwd CAGR |
|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | — | 3.0B | 3.7B | 4.3B | 5.1B | 18.7% | 5.5B | 5.9B | 6.5B | 13.4% |
| EPS | 3.57 | 4.09 | 3.76 | 5.26 | 6.00 | 13.9% | 6.38 | 7.12 | 7.81 | 14.1% |
| Shares | — | 55.7M | 56.6M | 57.4M | 58.1M | +4.4% | 58.3M | — | — | — |
| Debt | — | 1.6B | 1.9B | 2.0B | 2.2B | 11.9% | 2.3B | — | — | — |
| Equity | — | 1.2B | 1.5B | 1.8B | 2.2B | 21.4% | — | — | — | — |
| Op CF | — | 272.5M | 376.7M | 347.2M | 564.3M | 27.5% | 608.4M | — | — | — |
| Inv CF | — | -186.2M | -182.7M | -390.1M | -513.2M | — | — | — | — | — |
| Fin CF | — | -32.3M | -0.6M | -2.2M | -11.8M | — | — | — | — | — |
SCORE BREAKDOWN
FUNDAMENTALS
SECTOR PEERS
Closest peers in Healthcare, ranked by industry match, size, and score similarity. Cross-listings of ENSG are excluded.
| Ticker | Company | Mkt Cap | StockRank | Signal |
|---|---|---|---|---|
| ENSG | The Ensign Group, Inc.(you) | $10.1B | 57 | Hold |
| PACS | PACS Group, Inc. | $6.8B | 74 | Buy |
| ACHC | Acadia Healthcare Company, Inc. | $2.7B | 57 | Hold |
| UHS | Universal Health Services, Inc. | $10.1B | 89 | Strong Buy |
| OPCH | Option Care Health, Inc. | $3.6B | 68 | Buy |
| SGRY | Surgery Partners, Inc. | $1.8B | 58 | Hold |
| EHC | Encompass Health Corporation | $11.9B | 91 | Strong Buy |
| LFST | LifeStance Health Group, Inc. | $4.7B | 80 | Buy |
| DVA | DaVita Inc. | $11.5B | 92 | Strong Buy |
| CHE | Chemed Corporation | $6.8B | 89 | Strong Buy |
Peer medians: ROE -30.2% · P/E 27.1x · Gross margin 58.3%